Atopic dermatitis and eczema: emergency care and effective treatment

Abstract

Objective — to study the effectiveness and safety of the use of combined topical agents with a triple mechanism of action (anti­inflammatory, antibacterial and antimycotic) in the treatment of patients with eczema and atopic dermatitis. Materials and methods. The study included 65 patients with various forms of eczema and atopic dermatitis. The control group consisted of 150 healthy individuals. The severity of allergic dermatosis was assessed according to the SCORAD scale, and the severity of itching — according to the ten­point numerical rating scale. The study of the skin microbiocenosis was carried out by the method of its direct qualitative and collective assessment. The quality of life assessment was carried out according to an authorized Ukrainian translation of DLQI. Results and discussion. The course of atopic dermatitis and eczema of various forms is accompanied by violations of the skin microbiocenosis with an increase in the total number of bacteria and fungi in the affected areas, which requires appropriate treatment. The advantages of the drug Triacutan were established over monocomponent topical corticosteroids for the treatment of patients with atopic dermatitis and various forms of eczema. During the first 3 days of treatment with the use of the Triacutan, the severity of erythema, edema, papule formation, and excoriation decreased. On the 5th day of treatment, the SCORAD index decreased by 13 times compared with the corresponding indicators before treatment. At the end of treatment, lower indices of SCORAD (by 3.8 times), DLQI (by 1.98 times), itching (by 1.75 times) were noted. At the end of the therapeutic course, normalization of the skin microbiocenosis was registered in patients who used the drug Triacutan. Conclusions. Complex therapy of allergic dermatoses using Triacutan cream or ointment is pathogenetically justified and provides a rapid clinical effect which is manifested by a decrease in the SCORAD and DLQI indexes, a pronounced decrease in itching and its objective signs, and normalization of the skin microbiocenosis. The use of Triacutan cream or ointment in the complex treatment of various forms of eczema and atopic dermatitis is safe.

Authors and Affiliations

N. Yu. Reznichenko, A. D. Dyudyun, G. I. Reznichenko

Keywords

Related Articles

Original or generic combined topic glucocorticosteroid. What are the differences?

The task of the doctor is to choose the optimal (from a clinical and economic point of view) for the patient drug among numerous analogues drugs containing the same active pharmaceutical ingredient (API). In the pharmaco...

Dynamics of prooxidant and antioxidant homeostasis rates in patients with rosacea in the process of integrated treatment

Objective — to determine the dynamics of prooxidant and antioxidant homeostasis rates in patients with rosacea by using an antioxidant drug in their multimodality treatment. Materials and methods. The study involved 64...

Onychomycosis: modern possibilities of topical therapy

Onychomycosis (OM) is an infectious fungal lesion of the nail plate, nail bed, matrix. It is characterized by extreme prevalence, long, recurrent course, torpidity to existing methods of treatment. Objectave — to increa...

How oral collagen intake can be useful in dermatology

Collagen is the main component of dermis. It represents as much as 75 % of dry skin weight. With aging, collagen content decreases in the skin, because of a reduced production by the fibroblasts and higher metabolism rat...

Soap Perolite in treatment of acne

The data are presented of the clinical study of the effectiveness of soap with the brand name Perolite, which includes benzoyl peroxide, and Perolite plus containing benzoyl peroxide and clindamycin for the local treatme...

Download PDF file
  • EP ID EP672068
  • DOI 10.30978/UJDVK2019-3-58
  • Views 84
  • Downloads 0

How To Cite

N. Yu. Reznichenko, A. D. Dyudyun, G. I. Reznichenko (2019). Atopic dermatitis and eczema: emergency care and effective treatment. Український журнал дерматології, венерології, косметології, 0(3), 58-68. https://europub.co.uk/articles/-A-672068